$JAN

JAN (JAN) – Research Analysts’ Weekly Ratings Changes

Analysts at several firms adjusted ratings and price targets for JAN (NYSE: JAN) in May 2026, with Scotiabank raising its target to $30 (from $28) and Barclays lifting to $30 (from $26), among others. In April, multiple firms initiated coverage with targets from $26 to $29. JAN also declared a quarterly dividend of $0.1599 per share, payable June 24 to holders of record June 12.

Original reporting
Published May 29, 2026, 7:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JAN (JAN) – Research Analysts’ Weekly Ratings Changes — source image
Decision brief

The 30-second read

$JANBullishMed
01

Why it matters

For traders, the actionable elements are (1) the dividend schedule (ex-dividend June 12, payable June 24) and (2) the clustering of raised price targets/upgrades that can influence short-term positioning and options flows. However, it does not introduce a new earnings print, deal, or regulatory event.

02

Market read

Net effect is modestly positive sentiment for JAN due to raised targets and disclosed insider buying, with a clear near-term calendar event around the June 12 ex-dividend date.

03

What to watch

Dividend yield and insider buying can support sentiment, but the article lacks details on occupancy, rent growth, leverage, or guidance—key drivers for REIT re-pricing.

Relevance 7/10Novelty 4/10Timing: Dividend paid June 24; record June 12; ex-dividend June 12.

Background

The article compiles recent weekly analyst rating/price-target changes for JAN and adds dividend timing plus director insider purchases disclosed via SEC filings.

Company-level read

Ticker impact

$JANBullishMedium confidence
Context

JAN’s dividend details, multiple analyst rating/price-target changes, and insider director buying are cited as recent company-specific developments.

Expected impact

Modest upside bias around the dividend/ex-dividend calendar and potential follow-through from higher targets; no single new fundamental catalyst beyond the declared dividend and disclosed buys.

Evidence & confidence

The piece aggregates analyst actions (target raises/upgrades) plus a declared quarterly dividend and SEC Form 4-style insider purchases. It does not provide new operating guidance, earnings, or transaction terms that would materially re-rate fundamentals immediately.

Market effects

Positive read-through for senior housing REIT sentiment as analyst coverage broadens and targets rise, though this is not a sector-wide policy/regulatory change.

None explicitly; the article only notes portfolio unit concentration in Florida and Texas.

Low; developments are US REIT-specific and driven by analyst actions/SEC insider disclosures.

Counterpoint

Analyst target hikes may reflect model/assumption updates rather than new fundamentals; without earnings or guidance, price may already price in the consensus.

Key entities

  • JAN

    US-listed REIT focused on senior housing; declared a quarterly dividend and saw multiple analyst rating/target changes.

  • John V. Arabia

    Director who bought 60,000 shares at an average $20.00 on March 23 (per the article’s SEC disclosure summary).

  • Charles J. Herman, Jr.

    Director who bought 5,500 shares at an average $20.00 on March 23 (per the article’s SEC disclosure summary).

Related articles

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JANLow

Janus Living, Inc. (JAN): Results of Operations and Financial Condition

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 ex99306302026.htm EX-99.3 Document Exhibit 99.3 Discussion and Reconciliation of Janus Living's Non-GAAP Financial Measures June 30, 2026 (Unaudited) Definitions Adjusted Fixed Charge Coverage Fixed Charge Coverage Adjusted EBITDAre divided by Fixed Charges. Adjusted Fi

$BTGMedAI 8/10

B2Gold Shares Surge 23% After Mali Permit Boosts Fekola Growth Outlook

B2Gold’s shares (BTG) rose 23.1% to $5.03 on Aug. 7 after Mali issued the Menankoto permit for the Fekola mine. B2Gold said Fekola Regional targets over 150,000 ounces annually from 2028 and tightened 2026 production guidance to 820,000–920,000 ounces. Adjusted EPS was $0.03 vs $0.07 consensus; cash was $287m.

Med

Centerra Gold (TSX:CG) Is Up 22.9% After Raising 2026 Gold Guidance And Boosting Shareholder Returns – Has The Bull Case Changed?

Simply Wall St reports Centerra Gold’s Q2 2026 results: US$442.71m sales and US$72.12m net income, plus a confirmed quarterly C$0.07 dividend. The company raised 2026 gold production guidance to 260,000 to 290,000 ounces and confirmed 2026 copper guidance of 50 to 60m pounds, alongside buybacks. The article cites 2028 targets of $1.6b revenue and $106.3m earnings.